Literature DB >> 19264039

HIF-1: a key mediator in hypoxia.

J M Adams1, L T Difazio, R H Rolandelli, J J Luján, Gy Haskó, B Csóka, Zs Selmeczy, Z H Németh.   

Abstract

The transcription factor HIF-1 is one of the principal mediators of homeostasis in human tissues exposed to hypoxia. It is implicated in virtually every process of rapid gene expression in response to low oxygen levels. The most common causes of tissue hypoxia are inflammation and/or insufficient circulation or a combination of both. Inflamed tissues and the areas surrounding malignant tumors are characterized by hypoxia and low concentrations of glucose. Serious and generalized inflammation can lead to sepsis and circulatory collapse resulting in acute or chronic tissue hypoxia in various vital organs which induces a rapid homeostatic process in all nucleated cells of affected organs in the human body. Under hypoxic conditions the alpha and beta subunits of HIF-1 make an active heterodimer and drive the transcription of over 60 genes important for cell survival, adaptation, anaerobic metabolism, immune reaction, cytokine production, vascularization and general tissue homeostasis. In addition, HIF-1 plays a key role in the development of physiological systems in fetal and postnatal life. It is also a critical mediator of cancer, lung and cardiovascular diseases. The better understanding of the functions of HIF-1 and the pharmacological modulation of its activity could mean a successful therapeutic approach to these diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264039     DOI: 10.1556/APhysiol.96.2009.1.2

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  51 in total

Review 1.  Phosphorylation mechanisms in intensive care medicine.

Authors:  Erica L Martin; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-09-04       Impact factor: 17.440

2.  A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.

Authors:  Guogui Sun; Wanning Hu; Yifang Lu; Yadi Wang
Journal:  Pathol Oncol Res       Date:  2013-05-09       Impact factor: 3.201

3.  Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia.

Authors:  Lei-Lei Tao; Shu-Jing Shi; Long-Bang Chen; Gui-Chun Huang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  HIF-1α may provide only short-term protection against ischemia-reperfusion injury in Sprague-Dawley myocardial cultures.

Authors:  Siyang Wang; Xin Shao; Xiaoxue Li; Xiaojuan Su; Yongxu Huo; Chunlei Yang
Journal:  Mol Clin Oncol       Date:  2016-02-03

Review 5.  Autophagy, a double-edged sword in anti-angiogenesis therapy.

Authors:  Jiatao Liu; Lulu Fan; Hua Wang; Guoping Sun
Journal:  Med Oncol       Date:  2015-12-29       Impact factor: 3.064

Review 6.  Molecular mechanisms underlying cardiotoxicity of novel cancer therapeutics.

Authors:  Simon Braumann; Stephan Baldus; Roman Pfister
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  The Role of Hypoxia-Inducible Factor in Wound Healing.

Authors:  Wan Xing Hong; Michael S Hu; Mikaela Esquivel; Grace Y Liang; Robert C Rennert; Adrian McArdle; Kevin J Paik; Dominik Duscher; Geoffrey C Gurtner; H Peter Lorenz; Michael T Longaker
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-05-01       Impact factor: 4.730

8.  Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.

Authors:  Pedro C Lara; Marta Lloret; Bernardino Clavo; Rosa M Apolinario; Luis Alberto Henríquez-Hernández; Elisa Bordón; Fausto Fontes; Agustín Rey
Journal:  Radiat Oncol       Date:  2009-08-06       Impact factor: 3.481

9.  Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress.

Authors:  Weiming Ouyang; Chikako Torigoe; Hui Fang; Tao Xie; David M Frucht
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

10.  The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.

Authors:  Shi-Yun Cui; Jia-Yuan Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Wei De; Rui Wang; Long-Bang Chen
Journal:  Cell Cycle       Date:  2013-08-07       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.